Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

SELL
$16.45 - $25.88 $674 - $1,061
-41 Closed
0 $0
Q1 2022

May 06, 2022

SELL
$22.67 - $28.01 $4,216 - $5,209
-186 Reduced 81.94%
41 $1,000
Q4 2021

Feb 10, 2022

BUY
$24.13 - $32.63 $5,477 - $7,407
227 New
227 $6,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.3B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Sageworth Trust CO Of South Dakota Portfolio

Follow Sageworth Trust CO Of South Dakota and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sageworth Trust CO Of South Dakota, based on Form 13F filings with the SEC.

News

Stay updated on Sageworth Trust CO Of South Dakota with notifications on news.